Glycobiarsol
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101661This classification denotes an antiprotozoal agent with the molecular formula C8H9AsNO5.Bi.O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E3U8347QWJ, chemically known as bismuth, (hydrogen n-glycoloylarsanilato)oxo- (8ci) but generally known as glycobiarsol, which bears US NIH Compound Identifier 16682839. European Medicines Agency schedules Glycobiarsol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07950MIG. The term GLYCOBIARSOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules glycobiarsol in its Anatomical Therapeutic Chemical (ATC) Classification. GLYCOBIARSOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, GLYCOBIARSOL remains the US FDA Preferred Term for this commodity. Glycobiarsol bears US NLM identifiers UMLS ID C0301343 and NCI Concept Code C76421. SMILES: [BI](=O)O[AS](=O)(O)C1CCC(NC(=O)CO)CC1.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.